Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Gupshup investor cuts value of its stake again, implying new valuation of $486M

From TechCrunch

By Manish Singh

December 31, 2024

Gupshup investor cuts value of its stake again, implying new valuation of $486M

Gupshup investor cuts value of its stake again, implying new valuation of $486M

Asset management firm Fidelity slashed the estimated worth of its stake in business messaging platform Gupshup by another 7.7% last month, lowering the value of its holding in the SaaS startup by a total of more than 65% since its investment in mid-2021.

One of the funds operated by the U.S. asset manager valued its holding in Gupshup at $5.62 million at the end of November, down from $6.09 million in October, according to a monthly disclosure.

Fidelity had originally invested $16.2 million from its Blue Chip Growth Fund in Gupshup in mid-2021 in a funding round that valued the San Francisco-headquartered startup at $1.4 billio .

According to Fidelity’s calculation, the asset manager now values Gupshup at $486 million.

Gupshup, which started its journey in India 17 years ago, raised $340 million in 2021 from a clutch of investors, including Tiger Global, Think Investments and Malabar Investments.

View original article on techcrunch.com

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Fidelity deepens valuation cut for SaaS startup Gupshup

Fidelity deepens valuation cut for SaaS startup Gupshup

Fidelity has slashed the estimated worth of its holding in SaaS startup Gupshup by over 20% in a month and by more than 50% since the original investment in the latest brutal markdown across private markets. The U.S. asset manager valued its holding in Gupshup at $8.08 million at the end of June, down from $10.15 […]

Jul 30, 2023

Fidelity deepens valuation cut for Reddit and Discord

Fidelity deepens valuation cut for Reddit and Discord

Fidelity has further slashed the estimated worth of its holding in social platform Reddit and chat app Discord as well as SaaS startup Gupshup, giving a preview into how the asset manager sees the impact of the ongoing slowdown in the public market on privately-held shares. Fidelity Blue Chip Growth Fund valued its holdings in […]

Jun 30, 2023

PharmEasy’s $5.6 billion value shrinks to $456 million, investor data shows

PharmEasy’s $5.6 billion value shrinks to $456 million, investor data shows

Indian online pharmacy PharmEasy’s valuation now stands at about $456 million, according to disclosures from its investor Janus Henderson, a 92% drop from its peak valuation of $5.6 billion. The British American global asset firm’s Global Research Fund values its holding of 12.9 million shares in PharmEasy at $766,043, according to its latest filing for the period ending September. The fund had originally spent $9.4 million to acquire these shares. The persistent low valuation comes despite Pha

Dec 25, 2024

Fidelity cuts Meta-backed Meesho valuation to $3.5 billion

Fidelity cuts Meta-backed Meesho valuation to $3.5 billion

Fidelity has cut the value of its holding in Meesho by 33.6% since the originalninvestment, giving the Indian social commerce startup a valuation of $3.5nbillion, adjusted for outstanding shares. The U.S. asset manager valued itsnholding in Meesho at $27.8 million at December’s end, down from the $41.9nmillion that it invested in […]

Jan 29, 2024

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Fidelity deepens valuation cut for SaaS startup Gupshup

Fidelity deepens valuation cut for SaaS startup Gupshup

Fidelity has slashed the estimated worth of its holding in SaaS startup Gupshup by over 20% in a month and by more than 50% since the original investment in the latest brutal markdown across private markets. The U.S. asset manager valued its holding in Gupshup at $8.08 million at the end of June, down from $10.15 […]

Jul 30, 2023

Fidelity deepens valuation cut for Reddit and Discord

Fidelity deepens valuation cut for Reddit and Discord

Fidelity has further slashed the estimated worth of its holding in social platform Reddit and chat app Discord as well as SaaS startup Gupshup, giving a preview into how the asset manager sees the impact of the ongoing slowdown in the public market on privately-held shares. Fidelity Blue Chip Growth Fund valued its holdings in […]

Jun 30, 2023

PharmEasy’s $5.6 billion value shrinks to $456 million, investor data shows

PharmEasy’s $5.6 billion value shrinks to $456 million, investor data shows

Indian online pharmacy PharmEasy’s valuation now stands at about $456 million, according to disclosures from its investor Janus Henderson, a 92% drop from its peak valuation of $5.6 billion. The British American global asset firm’s Global Research Fund values its holding of 12.9 million shares in PharmEasy at $766,043, according to its latest filing for the period ending September. The fund had originally spent $9.4 million to acquire these shares. The persistent low valuation comes despite Pha

Dec 25, 2024

Fidelity cuts Meta-backed Meesho valuation to $3.5 billion

Fidelity cuts Meta-backed Meesho valuation to $3.5 billion

Fidelity has cut the value of its holding in Meesho by 33.6% since the originalninvestment, giving the Indian social commerce startup a valuation of $3.5nbillion, adjusted for outstanding shares. The U.S. asset manager valued itsnholding in Meesho at $27.8 million at December’s end, down from the $41.9nmillion that it invested in […]

Jan 29, 2024